NCT06313164View on ClinicalTrials.gov

The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients

NACompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

June 20, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

February 29, 2024

Conditions
Type 2 Diabetes
Interventions
DIETARY_SUPPLEMENT

enhanced glutathione

L-glutathione (in combination with tannin, low molecular weight chitosan and polyethylene glycol)

OTHER

placebo comparator

placebo group

Trial Locations (1)

630090

Center of New Medical Technologies, Novosibirsk

Sponsors
All Listed Sponsors
collaborator

Center of New Medical Technologies

OTHER

lead

S.LAB (SOLOWAYS)

OTHER

NCT06313164 - The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter